1-8 of 8
Jeanette Eckel-Passow
Close
Sort by
Journal Articles

Global Genomic Status At Diagnosis Informs Clinical Outcome in B-Chronic Lymphocytic Leukemia: Stable Versus Progressive Disease

Daniel L. Van Dyke, Ph.D., Jeannette G Rustin, Stephanie A. Smoley, Jeanette Eckel Passow, Ph.D., Ruchi G. Sharma, Esteban Braggio, PhD, Tait D. Shanafelt, MD, Neil Kay, MD
Journal: Blood
Blood (2011) 118 (21): 1772.
https://doi.org/10.1182/blood.V118.21.1772.1772
Published: 2011
Journal Articles

Progressive but Previously Untreated CLL Patients with Greater Array CGH Complexity Exhibit A Less Durable Response to Chemoimmunotherapy

Neil E. Kay, Jeanette Eckel Passow, Esteban Braggio, Scott Van Wier, Tait Shanafelt, Daniel L. Van Dyke, PhD, Diane F. Jelinek, PhD, Renee Tschumper, Thomas J. Kipps, MD, PhD, John C. Byrd, MD, Rafael Fonseca
Journal: Blood
Blood (2010) 116 (21): 2406.
https://doi.org/10.1182/blood.V116.21.2406.2406
Published: 2010
Journal Articles

Longitudinal Genomic Analyses In Chronic Lymphocytic Leukemia (CLL) Patients Reveal Clonal Relationship and Genomic Evolution In Disease Progression and After Therapy

Esteban Braggio, Neil E. Kay, Scott Van Wier, Stephanie Smoley, Jeanette Eckel-Passow, Traci Sassoon, Daniel L. Van Dyke, PhD, Diane F. Jelinek, PhD, Tait Shanafelt, MD, Renee Tschumper, Mike Barrett, Thomas J. Kipps, MD, PhD, John C. Byrd, MD, Rafael Fonseca
Journal: Blood
Blood (2010) 116 (21): 3605.
https://doi.org/10.1182/blood.V116.21.3605.3605
Published: 2010
Journal Articles

LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis

Albert Gutierrez, Jr, Renee C. Tschumper, Xiaosheng Wu, Tait D. Shanafelt, Jeanette Eckel-Passow, Paul M. Huddleston, III, Susan L. Slager, Neil E. Kay, Diane F. Jelinek
Journal: Blood
Blood (2010) 116 (16): 2975–2983.
https://doi.org/10.1182/blood-2010-02-269878
Published: 2010
Includes: Supplemental data
Journal Articles

Whole Genome Copy Number Variation Analysis of Chronic Lymphocytic Leukemia (CLL) Cells From Early-Intermediate Stage, High Risk CLL Patients Prior to First Treatment Reveals New Loss of Heterozygosity and Duplication Events in the CLL Genome.

Steven A. Schichman, MD, PhD, Annjanette Stone, BS, Maria Winters, MPH, Weleetka Carter, BS, Lori Frederick, BS, Jeanette Eckel-Passow, Ph.D., Timothy G. Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Clive S. Zent, MD, David S. Viswanatha, MD
Journal: Blood
Blood (2009) 114 (22): 1265.
https://doi.org/10.1182/blood.V114.22.1265.1265
Published: 2009
Journal Articles

Aberrant Regulation of the LEF-1 Locus in Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia (CLL): A Possible Role for Epigenetic Regulation.

Albert Gutierrez, Jr., Renee Tschumper, Tait D. Shanafelt, M.D., Jeanette Eckel-Passow, Ph.D., Neil E. Kay, MD, Diane F. Jelinek, PhD
Journal: Blood
Blood (2009) 114 (22): 669.
https://doi.org/10.1182/blood.V114.22.669.669
Published: 2009
Journal Articles

Complex Interstitial Deletions of 11q and Copy-Neutral Loss of Heterozygosity of 11q Are Detected by Whole Genome Copy Number Variation Analysis of Early-Intermediate Stage, High Risk Chronic Lymphocytic Leukemia Patients.

Steven A. Schichman, MD, PhD, Annjanette Stone, BS, Maria Winters, MPH, Weleetka Carter, BS, Lori Frederick, BS, Jeanette Eckel-Passow, Ph.D., Timothy G. Call, MD, Tait D. Shanafelt, M.D., Neil E. Kay, MD, Clive S. Zent, MD, David S. Viswanatha, MD
Journal: Blood
Blood (2009) 114 (22): 1245.
https://doi.org/10.1182/blood.V114.22.1245.1245
Published: 2009
Journal Articles

Overexpression of the LEF-1 and TCF4 Transcription Factors in B-CLL: Further Evidence for a Role of the Wnt Signaling Pathway in B-CLL Biology and Leukemogenesis

Albert Gutierrez, BS, Renee Tschumper, Jeanette Eckel-Passow, PhD, Neil E. Kay, MD, Diane F. Jelinek, PhD
Journal: Blood
Blood (2008) 112 (11): 544.
https://doi.org/10.1182/blood.V112.11.544.544
Published: 2008